173rd Expert Panel Meeting

Draft Documents

Amended Safety Assessment of 2-Bromo-2-Nitropropane-1,3-Diol as Used in Cosmetics

> Download PDF (5.91MB, 103PP)

Amended Safety Assessment of 2-Nitro-p-Phenylenediamine and 4-Nitro-o-Phenylenediamine as Used in Cosmetics

> Download PDF (11.71MB, 113PP)

Amended Safety Assessment of Oxyquinoline and Oxyquinoline Sulfate as Used in Cosmetics

> Download PDF (2.68MB, 59PP)

Safety Assessment of Dimer Dilinoleates as Used in Cosmetics

> Download PDF (5.38MB, 52PP)

Safety Assessment of Lactobacillus Ferment Ingredients as Used in Cosmetics

> Download PDF (15.56MB, 318PP)

Tentative Documents

Amended Safety Assessment of Cocoyl Hydrolyzed Collagen Ingredients as Used in Cosmetics

> Download PDF (4.06MB, 89PP)

Amended Safety Assessment of Pyrogallol as Used in Cosmetics

> Download PDF (3.03MB, 86PP)

Final Documents

Amended Safety Assessment of 4-Chloro-2-Aminophenol as Used in Cosmetics

> Download PDF (1.65MB, 63PP)

Amended Safety Assessment of Propylene Carbonate as Used in Cosmetics

> Download PDF (4.53MB, 74PP)

Safety Assessment of Paeonia suffruticosa-Derived Ingredients as Used in Cosmetics

> Download PDF (2.27MB, 70PP)

Safety Assessment of Tetrabromophenol Blue as Used in Cosmetics

> Download PDF (1.88MB, 36PP)

Past Panel Meetings

March 12 - 13 2026
175th Expert Panel Meeting
Virtual
> Read More
September 08 - 09 2025
174th Expert Panel Meeting
Virtual
> Read More
March 13 - 14 2025
172nd Expert Panel Meeting
Marriott Georgetown
1221 22nd St., NW
Washington, DC 20037
> Read More
December 02 - 03 2024
171st Expert Panel Meeting
Online
> Read More
> View More Past Panel Meetings

Jun 09, 2025 - Jun 10, 2025
Westin Georgetown
2350 M Street, NW
Washington, DC 20037

Related Documents

Data Supplement - Wave2 - June 2025

CIR
> Download PDF (2.03MB, 35PP)

Presentation: New data supporting the use of read across in the safety assessment of DDDE as a cosmetic ingredient - Mishra & Petry

ToxMinds
> Download PDF (775.28kB, 16PP)

Presentation: Application of Current Read-Across Methodologies to the Safety Assessment of a Cosmetic Ingredient - Ator

Toxservices
> Download PDF (2.08MB, 23PP)

Presentation: FDA’s views on cosmetics vs. drugs - Petro

FDA
> Download PDF (1.79MB, 30PP)

**Agenda Update**

Thomas Petry and Sanghamitra Mishra from ToxMinds will join Jennifer Ator during the presentation of safety data with regard to prostaglandin ingredients.

555 13th Street, NW
Suite 300W
Washington, DC 20004

© 2016 Cosmetic Ingredient Review